PremiumPremiumEntertainmentOprah says she's on a weight-loss drug and ‘done with the shaming’New York Times: 'I have a predisposition that no amount of willpower is going to control.'14 Dec 12:27 AM
RetailChemist Warehouse eyed up in huge merger bidBrash newcomer would merge to create huge new pharmacy company.10 Dec 11:44 PM
New ZealandIwi leader fears lifting pseudoephedrine ban will put more P on the streets'You’re not doing your country any good to put it on the shelves.'10 Dec 04:02 PM
PremiumPremiumOpinionJarrod Gilbert: The good drugs are returning to chemistsOPINION: The damage caused by stopping pseudoephedrine has been done.10 Dec 04:00 PM
New Zealand'Fantastic news': Mum cancer-free after international medical trialHamilton woman Lisa Martin was among those whose aggressive cancer was eliminated.08 Dec 04:00 PM
PoliticsFocus Live: Coalition Govt agrees to allow the sale of PseudoephedrineAct leader David Seymour at the signing of the coalition agreement with National and NZ First says pseudoephedrine will be back on shelves in time for next winter. Video / Mark MitchellWatch23 Nov 11:11 PM
HealthcareEbos Group's pet project is off, shares fall sharply as trading resumesEbos had been in a trading halt since last week.21 Nov 10:35 PM
PremiumPremiumLifestyleMenopause checklist: Questions to ask your doctor about HRTTelegraph: Considering hormone replacement therapy? Here's what you need to know.21 Nov 09:13 PM
PremiumPremiumNew Zealand'Pretty alarmed': Thousands of Kiwis with ADHD forced to switch drugs after supply problemsGlobal demand has been blamed for the shortage of Teva, a common ADHD drug.19 Nov 04:00 PM
PremiumPremiumLifestyleCan some antidepressants cause lasting sexual problems?NY Times: Some patients say symptoms persist long after they've stopped taking SSRIs.15 Nov 07:02 PM
PremiumPremiumBanking and financeObesity drug cuts risk of death by 18 per centWegovy has been found to have a 'quite profound' effect on reducing heart attack risk.11 Nov 10:20 PM
PremiumPremiumPoliticsPseudoephedrine question reflects failure of meth policy - expert"We have taken the eye off methamphetamine."10 Nov 08:00 PM
PremiumPremiumLifestyle‘Meno-washing’: Are midlife women being scammed?Telegraph: Menopause has come out of the shadows. So have the snake oil merchants.06 Nov 04:00 PM
PremiumPremiumLifestyleSome psychiatrists have started prescribing Ozempic. Others are worriedNew York Times: 'These medications were not studied well or designed for this population.'06 Nov 04:00 PM
PremiumPremiumBusinessMedicinal cannabis producers gear up to sell products prescription-freeRule change a 'surprise' but health regulator claims potential safety issues exist.31 Oct 07:19 PM
PremiumPremiumLifestyleWhat is behind the unexpected decline in dementia?Financial Times: Global data on new cases of dementia offers an unexpected ray of hope.31 Oct 12:07 AM
New ZealandPharmac CEO's fate revealed over Rachel Smalley email sagaPharmac's board met today amid a deepening crisis over internal emails.27 Oct 03:33 AM
PremiumPremiumNew ZealandPharmac email crisis: Emailer apologises to Smalley; Chair meets bosses; Calls for CEO sackingThe PM steps into the Pharmac email row, labelling comments 'totally unacceptable'.09 Oct 03:48 AM
PremiumPremiumBanking and financeWestern companies take slow steps towards China ‘de-risking’Financial Times: Strategies focus on ways to insulate China operations, not reduce them.25 Sep 09:55 PM
New ZealandYoung mum's $100k bill for cancer drugs that has political parties at oddsAdrienne Smithson says her 'world was tipped upside down' after her diagnosis at age 44.12 Sep 05:00 PM
PremiumPremiumBanking and financeOpinion: The economic promise of anti-obesity drugsFinancial Times: Over 1 billion people worldwide are obese, according to the WHO.07 Sep 08:00 PM
PremiumPremiumBusinessHow Ozempic and Wegovy are reshaping Denmark's economyNew York Times: Novo Nordisk’s market value has exceeded the size of the Danish economy.29 Aug 10:38 PM
PremiumPremiumWorldSuperbugs: Why it’s so hard to stop the ‘silent pandemic’Financial Times: Antimicrobial resistance already kills millions - and it's getting worse.29 Aug 05:00 PM
New Zealand'We are in a crisis': Patients call for access to new medsMyLifeMatters collective represents over a million patients with life-limiting conditions.28 Aug 12:26 AM
PremiumPremiumOpinionOpinion | Pharmac in the dark shadow of adversarial politicsOPINION: Drug-buying agency has received huge criticism. For what?21 Aug 05:00 PM
OpinionAndrew Young: Time to mobilise to fight cancerOPINION: Why your support for the Cancer Society's Daffodil Day matters.20 Aug 05:00 PM
PremiumPremiumLifestyleA shot in the dark: Nobody knows why new weight-loss drugs workNY Times: Drug makers 'got lucky', experts say - and there's still a lot they don't know.17 Aug 10:11 PM
PremiumPremiumLifestyleOzempic, saunas and cottage cheese: 5 wellness trends to watchNew York Times: A look at the pills, products and practices that have popped up in 2023.15 Aug 05:00 PM
New Zealand'Deliberate and unethical': Pharmacist stole methadone, topped up bottles with waterJohn Collett moved the methadone to a small bottle, then put it in his pocket.14 Aug 05:00 PM
PremiumPremiumOpinionOpinion: A single Ozempic injection almost hospitalised meTelegraph: 'I never expected a licensed drug to make me feel so bad.'10 Aug 07:41 PM
WorldFirst pill to treat postnatal depression approved in USPostpartum depression can continue for months or even years.05 Aug 12:45 AM
KahuFree medicine deliveries will help address healthcare inequity for Māori and Pasifika - pharmacistFor many, just driving to the pharmacy is a significant barrier.01 Aug 08:38 PM
PremiumPremiumOpinionSickness, misery and shedding kilos: My first two months on OzempicTelegraph: Yes, semaglutide works. But there's a price to pay, says a UK patient.30 Jul 09:27 PM
PremiumPremiumLifestyleThe risks of taking drugs like Ozempic when you’re over 65New York Times: The weight-loss equation changes for older adults, experts say.25 Jul 02:45 AM